Understanding the Financial Burden
This study evaluates the direct out-of-pocket expenditure incurred by patients for diabetes care.
Focus: Annual cost + Cost differences + Link between cost and quality
View Study →Real-World Evidence on Cost, Quality, and Cardiovascular Risk-Shaping the Future of Chronic Disease Management
The Problem We Are Solving
Diabetes care is fragmented, inconsistent, and largely reactive
Our Approach
DEDICOM-II adopts a holistic, evidence-driven framework to understand diabetes across three interconnected dimensions:
This approach ensures real-world validity, representativeness and scalability
Evaluating financial burden and access barriers
Assessing adherence to clinical standards
Projecting long-term cardiovascular outcomes
Research & Evidence
DEDICOM-II is grounded in robust, community-based research spanning cost, quality, and long-term risk in diabetes care.
Featured Research
Impact at Scale
DEDICOM-II provides actionable insights for multiple stakeholders
Innovation
DEDICOM-II represents a shift from traditionalto multi-dimensional evidence framework.
Global Significance
DEDICOM-II offers globally relevant insights:
Contributes to building equitable, scalable, and sustainable chronic disease systems globally.
Collaborators & Partners
DEDICOM-II is powered by clinical and public health research.
DEDICOM-II highlights the urgent need to rethink diabetes care—not just clinically, but systemically. Transforming Diabetes Care Through Evidence and Collaboration